K. Styczkiewicz, P. Plata, and K. Polityńska, “Should age disqualify from life-prolonging therapy? Successful adjuvant immunotherapy in an 88-year-old octogenarian with melanoma and high cardiovascular risk. ”, OncoReview, Jul. 2026.